Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dense Breasts”

136 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 136 results

Not applicableUnknownNCT02506361
What this trial is testing

Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 800
Testing effectiveness (Phase 2)Ended earlyNCT01498588
What this trial is testing

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+3 more
Emory University 7
Testing effectiveness (Phase 2)Study completedNCT00470301
What this trial is testing

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast CancerMale Breast CancerStage II Breast Cancer+3 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)UnknownNCT00496795
What this trial is testing

Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer

Who this might be right for
Stage III Breast Cancer AJCC V7
University of Bergen 100
Not applicableUnknownNCT00436709
What this trial is testing

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Study completedNCT03301350
What this trial is testing

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
University of Wisconsin, Madison 29
Not applicableNot Yet RecruitingNCT07114679
What this trial is testing

Molecular Breast Imaging (MBI)-Guided Biopsy

Who this might be right for
Breast Cancer DetectionBreast NeoplasmMolecular Imaging+2 more
Smart Breast Corp. 250
Not applicableUnknownNCT01004666
What this trial is testing

Molecular Breast Imaging: A Novel Technology for Detection of Malignant Breast Lesions

Who this might be right for
Small Breast LesionsDense Breast TissueDiscrepancy With Clinical Examination+1 more
Tel-Aviv Sourasky Medical Center 500
Not applicableStudy completedNCT07521397
What this trial is testing

Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.

Who this might be right for
Breast CancerEarly Stage Breast CancerAdjuvant Chemotherapy+2 more
Hellenic Cooperative Oncology Group 5,358
Not applicableUnknownNCT02066142
What this trial is testing

Tomosynthesis (TS) Versus Ultrasonography (US) in Women With Dense Breast

Who this might be right for
Breast Cancer
University of Genova 4,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT02965950
What this trial is testing

The p53 Breast Cancer Trial

Who this might be right for
Locally Advanced Breast CancerMetastatic Breast Carcinoma
Haukeland University Hospital 190
Testing effectiveness (Phase 2)Study completedNCT00119262
What this trial is testing

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Who this might be right for
Male Breast CancerStage II Breast CancerStage IIIA Breast Cancer+1 more
National Cancer Institute (NCI) 226
Not applicableStudy completedNCT00615901
What this trial is testing

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 38
Not applicableStudy completedNCT02650778
What this trial is testing

Automated Breast Ultrasound Screening

Who this might be right for
Breast Cancer
Northeastern Ohio Radiology Research and Education Fund 2,257
Testing effectiveness (Phase 2)Study completedNCT01328249
What this trial is testing

Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer

Who this might be right for
HER2-normal
Eisai Inc. 81
Not applicableLooking for participantsNCT05667532
What this trial is testing

The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,000
Testing effectiveness (Phase 2)Study completedNCT00394251
What this trial is testing

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Celgene 197
Not applicableUnknownNCT02209389
What this trial is testing

OctavaPink for Women With Dense Breast After Negative Mammography

Who this might be right for
Breast Cancer
Eventus Diagnostics Ltd 1,750
Testing effectiveness (Phase 2)Ended earlyNCT03329378
What this trial is testing

Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer
Icahn School of Medicine at Mount Sinai 7
Not applicableLooking for participantsNCT06127797
What this trial is testing

Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,000
Load More Results